The store will not work correctly when cookies are disabled.
4-(7-methoxy-1-methyl-9H-pyrido[3,4-b]indol-9-yl)-N,N-dimethylbutan-1-amine
ID: ALA2012573
PubChem CID: 54575718
Max Phase: Preclinical
Molecular Formula: C19H25N3O
Molecular Weight: 311.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c3ccnc(C)c3n(CCCCN(C)C)c2c1
Standard InChI: InChI=1S/C19H25N3O/c1-14-19-17(9-10-20-14)16-8-7-15(23-4)13-18(16)22(19)12-6-5-11-21(2)3/h7-10,13H,5-6,11-12H2,1-4H3
Standard InChI Key: VHNUNRTXGXLCOB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-3.0910 1.3241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0922 0.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3778 0.0847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3796 1.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6647 1.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6644 0.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8745 0.2408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8750 1.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3896 0.9117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4338 0.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7730 1.7531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2826 2.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5391 2.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9168 0.3281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8065 0.0856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.5154 0.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6188 -0.5429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1696 -1.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9138 -1.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4646 -2.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2088 -3.3372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4021 -3.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7596 -3.9506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 11 2 0
11 12 1 0
2 3 1 0
12 13 2 0
13 8 1 0
3 6 2 0
10 14 1 0
6 7 1 0
2 15 1 0
7 9 1 0
15 16 1 0
8 5 1 0
7 17 1 0
1 2 2 0
17 18 1 0
5 4 2 0
18 19 1 0
8 9 2 0
19 20 1 0
4 1 1 0
20 21 1 0
9 10 1 0
21 22 1 0
5 6 1 0
21 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 311.43 | Molecular Weight (Monoisotopic): 311.1998 | AlogP: 3.85 | #Rotatable Bonds: 6 |
Polar Surface Area: 30.29 | Molecular Species: BASE | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.79 | CX LogP: 2.67 | CX LogD: 0.29 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.65 | Np Likeness Score: -0.43 |
References
1. Cuny GD, Ulyanova NP, Patnaik D, Liu JF, Lin X, Auerbach K, Ray SS, Xian J, Glicksman MA, Stein RL, Higgins JM.. (2012) Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors., 22 (5): [PMID:22335895] [10.1016/j.bmcl.2012.01.028] |